Hypertension Update Flashcards

1
Q

HTN =

A

High BP defined as SBP >140 or DBP >90

Having been told at least 2 times by health care provider that one has HBP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PreHTN

A

Gray area of 120-139/80-89
Develops into HTN in 50% of population within 4 yrs
Should be monitored annually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Benefit of lowering BP

A

Reduction in incidence of stroke, MI, HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mechanisms for development of HTN

A

Complex interplay of individual’s heart and BP

Major Players: CNS, kidneys, Local endothelial factors, genetic, lifestyle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pathophysiology

A

In some cases, the arteriolar constriction may be due to some secondary underlying disorder.
CNS and ANS regulate blood pressure through stimulation of alpha and beta receptors on the arterioles and venules.
Kidneys also provide humeral response to maintain blood pressure in the presence of decreased blood flow to the kidneys - results in the release of renin and its subsequent vasoconstrictors, angiotnesin and aldosterone.

Pathologic disruption in any of these systems can lead to hypertension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Classification

A

Classification SBP DBP

Normal 160 OR >100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CVD Risk Factors

A

Hypertension*
Cigarette smoking
Obesity* (BMI >30 kg/m2)
Physical inactivity
Dyslipidemia*
Diabetes mellitus*
Microalbuminuria or estimated GFR <60 ml/min
Age (older than 55 for men, 65 for women)
Family history of premature CVD
(men under age 55 or women under age 65)

*components of metabolic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Factors that Increase Susceptibility to HTN

A
Age
Ethnicity
Less educated
Lower socioeconomic status
Cigarette smoking
Sedentary lifestyle
Obesity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Protective Factors Against HTN

A

Not smoking
Low-fat, low sodium diet
Genetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Objectives for Eval of pts with Documented HTN

A
  1. Assess lifestyle and identify other CV risk factors or concomitant disorders that affects prognosis and guides treatment.
  2. Reveal identifiable causes of high BP.
  3. Assess the presence or absence of target organ damage and CVD.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Target Organ Damage

A
Heart
 Left ventricular hypertrophy
 Angina or prior myocardial infarction
 Prior coronary revascularization
 Heart failure
Brain
 Stroke or transient ischemic attack
Chronic kidney disease
Peripheral arterial disease
Retinopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Symptoms of early HTN

A

May be asymptomatic

Blurred vision
Chest pain
Dizziness
Dyspnea
Fatigue
Flushing
Headaches
Hematuria
Muscle cramps
Palpitations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Identifiable/secondary Causes of HTN

A
Sleep apnea
Drug-induced or related causes
Chronic kidney disease
Primary aldosteronism
Renovascular disease
Chronic steroid therapy and Cushing’s syndrome
Pheochromocytoma
Coarctation of the aorta
Thyroid or parathyroid disease
Gout
Toxemia of Pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drug-induced causes of HTN

A
Oral contraceptives
Steroids
NSAIDs 
Nasal decongestants/cold remedies
Appetite Suppressants
Sodium bicarbonate products (antacids)
Licorice
Tricyclic antidepressants
Monamine oxidase inhibitors
Cyclosporine
Erythropoietin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fam Hx

A
There is a higher incidence in children who exhibit other risk factors for cardiovascular disease or have hypertensive parents
Ask Fam Hx of:
Premature Coronary artery disease
Peripheral vascular disease
Diabetes mellitus
Hypertension
Stroke, TIA, or seizures
Renal disease
Dyslipidemia
Dietary History, especially
Sodium
Cholesterol
Fat 
Alcohol use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ambulatory BP Monitoring

A

ABPM is warranted for evaluation of “white-coat” HTN in the absence of target organ injury.
ABPM values are usually lower than clinic readings.
Awake, individuals with hypertension have an average BP of >135/85 mmHg and during sleep >120/75 mmHg.
BP drops by 10 to 20% during the night; if not, consider renal disease or LVH.

17
Q

Self-Measurement of BP

A

Provides information on:
Response to antihypertensive therapy
Improving adherence with therapy
Evaluating white-coat HTN

Home measurement of >135/85 mmHg is generally considered to be hypertensive.

Home measurement devices should be checked regularly. Bring to office and compare with office BP measurement.

18
Q

PE

A

Record height and weight –BMI!
Funduscopic examination
Examine neck - carotid bruits, distended veins, thyromegaly
Heart - increased rate, size, precordial heave, clicks, murmurs, arrhythmias, and S3 or S4
Abdomen - bruits, enlarged kidneys, masses, abnormal aortic pulsations
Extremities - decreased or absent pulses, bruits, or edema
Neurologic assessment

19
Q

Labs

A

Routine Tests
Electrocardiogram
Urinalysis
Blood glucose, and hematocrit or complete blood count (CBC)
Comprehensive metabolic panel
Serum potassium, creatinine, or the corresponding estimated GFR
Lipid profile, after 9- to 12-hour fast, that includes high-density and low-density lipoprotein cholesterol, and triglycerides
Thyroid –stimulating hormone (TSH)
Optional Tests
Measurement of urinary albumin excretion or albumin/creatinine ratio

20
Q

DD

A

Differentiate b/t Primary, Pseudo-, and Secondary HTN
PseudoHTN caused by faulty BP reading

Suspect secondary hypertension
Drug therapy ineffective
Elevate blood pressure < age 25 or >60 years
Associated symptoms are present

21
Q

Goals of Tx

A

Reduce CVD and renal morbidity and mortality.

BP targets <130/80 in pts with CRD or DM

22
Q

Lifestyle Modifications

A
Wt loss
Adopt DASH eating plan
Dietary Na reduction
Physical activity
Moderation of ETOH comsumption
23
Q

Management for each classification

A

Normal: Lifestyle modification
PreHTN: Lifestyle modification. Only initiate meds if there is a compelling indication
Stage 1: Lifestyle mod. and initiate Thyazide-type diuretic. Consider ACE-I, ARB, BB, CCB
Stage 2: Lifestyle mod and 2 drug tx

24
Q

Diuretics

A

Thiazides - hydrodiuril
Loop - Ethacrynic acid
Potassium-sparing agents: spironolactone
First-line therapy for systolic hypertension and essential hypertension

25
Q

ACE Inhibitors

A

First line therapy for comorbid conditions of congestive heart failure and diabetes mellitus
Can increase serum potassium—should be checked one month after starting a patient on an ACE
Side effects: cough, angioedema, rash
Known as the “pril” drugs e.g. lisinopril, enalapril

26
Q

Angiotensin II Receptor Blockers

A

Bind to angiotensin type-1 receptors which blocks the physiological effects of angiotensin II
Reduces BP, vascular resistance, smooth muscle contraction
6 available ARBs-slightly different pharmokinetics
Equivalent to ACE-I, CCB, BB, and diuretics
Less effective in African Americans
Can slow progression of LV hypertrophy
Safe with elderly patients

Ex. Candesartan, eprosartan, irbesartan,

27
Q

Beta Blockers in Older Adults

A

Do not use in pt’s >60yo unless they have a comorbid condition like CHF or ischemic heart dz
If you use them, avoid atenolol
Metoprolol is drug of choice in older pts

28
Q

Beta Blockers

A

Indicated for use after myocardial infarction (shown to reduce mortality)
Used in congestive heart failure
Useful with comorbid condition of essential tremor
Cautionary note with asthma, COPD,peripheral vascular disease
Common side effects: bradycardia, heart failure, fatigue, decreased exercise tolerance

29
Q

Calcium Antagonists

A

Two types: dihydropyridines
(e.g. felodipine)
nondihydropyridines
(e.g. verapamil)

Can be used with isolated systolic hypertension
Should not be used with patients who have congestive heart failure
Side effects: edema, constipation

30
Q

Direct Renin Inhibitors

A
Aliskiren (Tekturna) (came out in 2008)
Inhibits the capacity of renin to form angiotensin I
24 hour BP control
Dosage 150 mg/day (initial)
Maintenance dose 150-300 mg/day
31
Q

Potential Unfavorable Effects in HTN meds

A

Thiazide diuretics should be used cautiously in gout or a history of significant hyponatremia.
BBs should be generally avoided in patients with asthma, reactive airways disease, or second- or third-degree heart block.
ACEIs and ARBs are contraindicated in pregnant women or those likely to become pregnant.
ACEIs should not be used in individuals with a history of angioedema.
Aldosterone antagonists and potassium-sparing diuretics can cause hyperkalemia.

32
Q

Potential Favorable Effects of HTN meds

A

Thiazide-type diuretics useful in slowing demineralization in osteoporosis.
BBs useful in the treatment of atrial tachyarrhythmias/fibrillation, migraine, thyrotoxicosis (short-term), essential tremor, or perioperative HTN.
CCBs useful in Raynaud’s syndrome and certain arrhythmias.
Alpha-blockers useful in prostatis

33
Q

F/U and Monitoring

A

Patients should return for follow up and adjustment of medications until the BP goal is reached.

More frequent visits for stage 2 HTN or with complicating comorbid conditions.

Serum potassium and creatinine monitored 1–2 times per year.
After BP at goal and stable, followup visits at 3- to 6-month intervals.

Comorbidities, such as heart failure, associated diseases, such as diabetes, and the need for laboratory tests influence the frequency of visits.